M. Ferreira

783 total citations
30 papers, 522 citations indexed

About

M. Ferreira is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, M. Ferreira has authored 30 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in M. Ferreira's work include Endometrial and Cervical Cancer Treatments (5 papers), Head and Neck Cancer Studies (5 papers) and MicroRNA in disease regulation (4 papers). M. Ferreira is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Head and Neck Cancer Studies (5 papers) and MicroRNA in disease regulation (4 papers). M. Ferreira collaborates with scholars based in Portugal, United States and Spain. M. Ferreira's co-authors include Guillermo Di Paola, Carlos Sananes, Adolfo Giaroli, Susana Vighi, Nidia Gómez Rueda, Rui Medeiros, Ana Luísa Teixeira, Joaquina Maurício, Juan E. Sardi and Adriana Bermúdez and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

M. Ferreira

27 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ferreira Portugal 9 259 209 167 160 145 30 522
Oudai Hassan United States 11 86 0.3× 318 1.5× 49 0.3× 260 1.6× 58 0.4× 26 602
Nicanor I. Barrena Medel United States 9 519 2.0× 87 0.4× 100 0.6× 71 0.4× 82 0.6× 9 650
Jeroen Depreeuw Belgium 9 289 1.1× 129 0.6× 41 0.2× 151 0.9× 29 0.2× 13 491
Shari Thomas United States 4 143 0.6× 50 0.2× 96 0.6× 44 0.3× 119 0.8× 9 443
Mitsutake Yano Japan 13 148 0.6× 174 0.8× 18 0.1× 91 0.6× 52 0.4× 54 455
Ning‐Fu Peng China 12 44 0.2× 61 0.3× 71 0.4× 131 0.8× 65 0.4× 20 356
Ying‐Yang Liao China 11 47 0.2× 73 0.3× 53 0.3× 141 0.9× 46 0.3× 15 308
N. Sakuragi Japan 11 183 0.7× 79 0.4× 41 0.2× 32 0.2× 56 0.4× 28 423
Valentina Zanfagnin United States 12 182 0.7× 76 0.4× 22 0.1× 54 0.3× 66 0.5× 24 470
Agustín Sánchez Rey Spain 13 59 0.2× 123 0.6× 30 0.2× 85 0.5× 79 0.5× 22 321

Countries citing papers authored by M. Ferreira

Since Specialization
Citations

This map shows the geographic impact of M. Ferreira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ferreira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ferreira more than expected).

Fields of papers citing papers by M. Ferreira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ferreira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ferreira. The network helps show where M. Ferreira may publish in the future.

Co-authorship network of co-authors of M. Ferreira

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ferreira. A scholar is included among the top collaborators of M. Ferreira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ferreira. M. Ferreira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferreira, M., Lina C. Binder, Thiago Fernandes Martins, et al.. (2025). High seroprevalence of Rickettsia spp. and molecular detection of Rickettsia amblyommatis in human-biting ticks from the eastern Amazon, Brazil. Parasites & Vectors. 18(1). 330–330.
2.
Martín‐Broto, Javier, Ricardo Fernández, M. Ferreira, et al.. (2024). Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma. Therapeutic Advances in Medical Oncology. 16. 2669780–2669780.
3.
Bartosch, Carla, et al.. (2022). Molecular Classification of Endometrial Carcinoma: Protocol for a Cohort Study. JMIR Research Protocols. 11(8). e34461–e34461. 4 indexed citations
4.
Mazières, Julien, Florian Guisier, M. Ferreira, et al.. (2021). 1341P NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes. Annals of Oncology. 32. S1023–S1024. 1 indexed citations
5.
Teixeira, Ana Luísa, Francisca Dias, Carlos Silva, et al.. (2021). AGO2 Expression Levels and Related Genetic Polymorphisms: Influence in Renal Cell Progression and Aggressive Phenotypes. Pharmacogenomics. 22(16). 1069–1079. 5 indexed citations
6.
Abreu, Mauro Henrique Nogueira Guimarães de, et al.. (2021). 536 Bevacizumab in cervical cancer – the experience of a comprehensive cancer center in northern Portugal. A31.3–A32.
7.
Vieira, Cláudia, et al.. (2018). The history of cancer pain and bone-targeted agents: 10 most commonly asked questions. Cancer Management and Research. Volume 11. 37–46. 2 indexed citations
8.
Ferreira, M., Ana Luísa Teixeira, Joaquina Maurício, et al.. (2017). Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis. Urologic Oncology Seminars and Original Investigations. 35(8). 532.e25–532.e30. 3 indexed citations
9.
Vieira, José Luiz Fernandes, et al.. (2017). Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to Plasmodium vivax in the Brazilian Amazon Basin. American Journal of Tropical Medicine and Hygiene. 96(5). 1171–1175. 4 indexed citations
10.
Rugo, Hope S., Olivier Trédan, Jungsil Ro, et al.. (2017). A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer. Breast Cancer Research and Treatment. 165(3). 601–609. 21 indexed citations
11.
12.
13.
Costa, Diogo Alpuim, et al.. (2014). Sinonasal Adenocarcinoma (Sna) - Experience of an Oncology Center. Annals of Oncology. 25. iv353–iv353. 1 indexed citations
14.
Teixeira, Ana Luísa, M. Ferreira, Joana Silva, et al.. (2013). Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients. Tumor Biology. 35(5). 4057–4066. 94 indexed citations
15.
Teixeira, Ana Luísa, M. Ferreira, Joana Assis, et al.. (2013). Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population. Molecular Biology Reports. 40(8). 4819–4826. 18 indexed citations
16.
Teixeira, Ana Luísa, M. Ferreira, Inês J. Marques, et al.. (2012). 891 Circulating MicroRNA-222 in Plasma – a Potential Biomarker for Renal Cell Carcinoma. European Journal of Cancer. 48. S216–S216. 3 indexed citations
17.
Ferreira, M., et al.. (2006). Treatment for acute lymphoblastic leukemia in children is associated with papillary carcinoma of thyroid, but not with thyroid disfunction.. PubMed. 58(5). 469–76. 3 indexed citations
18.
Sardi, Juan E., Adolfo Giaroli, Carlos Sananes, et al.. (1998). Long-Term Follow-Up of the First Randomized Trial Using Neoadjuvant Chemotherapy in Stage Ib Squamous Carcinoma of the Cervix. Obstetrical & Gynecological Survey. 53(2). 78–79. 2 indexed citations
19.
Sardi, Juan E., Adolfo Giaroli, Carlos Sananes, et al.. (1997). Long-Term Follow-up of the First Randomized Trial Using Neoadjuvant Chemotherapy in Stage Ib Squamous Carcinoma of the Cervix: The Final Results. Gynecologic Oncology. 67(1). 61–69. 200 indexed citations
20.
Sardi, Juan P., Adolfo Giaroli, Carlos Sananes, et al.. (1996). Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: an unexpected therapeutic management. International Journal of Gynecological Cancer. 6(2). 85–93. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oudai Hassan Breakdown of academic impact, for papers by Nicanor I. Barrena Medel Breakdown of academic impact, for papers by Jeroen Depreeuw Breakdown of academic impact, for papers by Shari Thomas Breakdown of academic impact, for papers by Mitsutake Yano Breakdown of academic impact, for papers by Ning‐Fu Peng Breakdown of academic impact, for papers by Ying‐Yang Liao Breakdown of academic impact, for papers by N. Sakuragi Breakdown of academic impact, for papers by Valentina Zanfagnin Breakdown of academic impact, for papers by Agustín Sánchez Rey
Rankless by CCL
2026